PRCT Q2 2024 Earnings — PROCEPT BioRobotics Corporation Revenue & Financial Results | Market Cap Arena

PRCTPROCEPT BioRobotics Corporation

$1B

Q2 2024 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$53M+61.2% YoY

Gross Profit

$31M59.0% margin

Operating Income

-$27M-50.3% margin

Net Income

-$26M-48.0% margin

EPS (Diluted)

$-0.50

QoQ Revenue Growth

+19.8%

Cash Flow

Operating Cash Flow

-$16M

Free Cash Flow

-$17M

Stock-Based Comp.

$8M

Balance Sheet

Total Assets

$374M

Total Liabilities

$123M

Stockholders' Equity

$252M

Cash & Equivalents

$214M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$53M	$33M	+61.2%
Gross Profit	$31M	$18M	+70.8%
Operating Income	-$27M	-$26M	-4.7%
Net Income	-$26M	-$25M	-1.3%

Geographic Segments

UNITED STATES

$48M89%

Outside the United States

$6M11%